This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 1000+ CE and professional development courses.

Get access starting at $49.95/yrLoading..

Goals and Learning Outcomes

The purpose of this course is to understand the differences between metabolic bone conditions and tumor-related illnesses, as they relate to the management of the orthopedic patient.

After taking this course, you should be able to:

  • Identify and differentiate between benign and malignant musculoskeletal tumors, soft tissue, muscle, and synovial tissue proliferations.
  • Discuss possible complications associated with orthopedic tumor disorders and management options for these conditions.

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/26

Course Originally Released On: 01/01/24

Course Authors

4.5 Average

Course Reviews

3778 reviews

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CEBroker.

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.